Serum concentrations of oxytocin, DHEA and follistatin are associated with osteoporosis or sarcopenia in communitydwelling postmenopausal women

Osteoporosis and sarcopenia are major health issues in postmenopausal women due to their high prevalence and association with several adverse outcomes. However, no biomarkers may be used for screening and diagnosis. The current study investigated potential biomarkers for osteoporosis and/or sarcopenia in postmenopausal women.